%D8%AF%D8%A7%D8%A8%D8%B3%D9%88%D9%86%D8%AF%D8%A7%D9%BE%D8%B3%D9%88%D9%86DapsonDapsonDapsoneDapsona%D8%AF%D8%A7%D9%BE%D8%B3%D9%88%D9%86DapsoniDapsone%D7%93%D7%A4%D7%A1%D7%95%D7%9FDapsonDapsone%E3%82%B8%E3%82%A2%E3%83%95%E3%82%A7%E3%83%8B%E3%83%AB%E3%82%B9%E3%83%AB%E3%83%9B%E3%83%B3%EB%8C%91%EC%86%90DapsonDapsonDapsona%E0%AC%A1%E0%AC%BE%E0%AC%AA%E0%AD%8D%E2%80%8C%E0%AC%B8%E0%AD%8B%E0%AC%A8%E0%AD%8DDapson%DA%89%D8%A7%D9%BE%D8%B3%D9%88%D9%86DapsonaDapson%C4%83%D0%94%D0%B0%D0%BF%D1%81%D0%BE%D0%BDDapsonDapsonDapson%E0%B0%A1%E0%B0%BE%E0%B0%AA%E0%B1%8D%E0%B0%B8%E0%B1%8B%E0%B0%A8%E0%B1%8D%E0%B9%81%E0%B8%94%E0%B8%9E%E0%B9%82%E0%B8%8B%E0%B8%99Dapsone%D0%94%D0%B0%D0%BF%D1%81%D0%BE%D0%BDDapsoneQ422226%E9%81%94%E6%99%AE%E9%A0%8C
about
P3781
Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian InfantsEfficacy of Dapsone as a Steroid Sparing Agent in Pemphigus VulgarisChlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated MalariaSafety and Efficacy Study of Dapsone Gel in Patients With Acne VulgarisA Safety and Efficacy Study of Dapsone Gel in Patients With Acne VulgarisIntermittent Preventive Treatment With Antimalarials in Kenyan InfantsPharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in AcneA Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment ProductsA Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial AcneSafety, Tolerability, and Pharmacokinetics of Dapsone in Acne VulgarisAczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of ColorStudy Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris (2019-07-11)
P4844
Dapsone for immune thrombocytopenic purpura in children and adults.Dapsone hypersensitivity syndrome: a clinico-epidemiological review.Dapsone-associated fixed drug eruption.Dapsone and azole interactions: A clinical perspective.Adverse effects from multi-drug therapy in leprosy: a Brazilian study.Dapsone and Nitroso Dapsone Activation of Naı̈ve T-Cells from Healthy Donors.Dapsone: a forgotten and underestimated treatment option for bullous pemphigoid?Dapsone is a potentially useful adjuvant therapy for bullous pemphigoid.Dapsone for topical use in extemporaneous preparations.Amino acid variants of HLA-DRB1 confer susceptibility to dapsone hypersensitivity syndrome in addition to HLA-B*13:01.[Topical corticosteroids as a therapeutic alternative in linear immunoglobulin A bullous dermatosis in childhood: case report]Bullous systemic lupus erythematosus - a case reportLinear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patientsDapsone and body mass index in subjects with multibacillary leprosy
P921
Q1151507-56E1AECC-3D38-4912-A052-C2A3E61EDD95Q1151507-6D98A78B-6BBF-4A26-A398-53C76EB77B5AQ187656-7C230717-D81D-4C73-8D28-D4FAACDCE9A6Q36956-1E8888B8-87CE-41C9-A3C3-B0B9824AB639Q36956-CC3F677E-9C30-4B22-A974-B2F90609D075Q6527832-1642BEA5-5F75-401F-A74B-F65E2C270012Q79928-B8F519D4-1B1A-4331-9C52-1254055CB3DDQ79928-EB0F9FC8-CE84-498B-9D5C-CF9D7E534DB9
P2176
Q61915282-FDCE8512-B1A5-4774-9DA3-E2CA6C82BDA1Q61917407-46EBDB54-4B96-4338-A6DA-4DB8D8F71450Q61921179-56B09CAC-E4FA-4437-BFC8-4E6A7799BE89Q61933103-41E974DB-CB8F-4AE2-9E4C-58AE8579DF12Q61975047-2191BDF9-F93B-4759-B5F2-906F77C4C59FQ61975062-D657A0F3-8844-4383-9C06-397BE7BEC1D6Q62105182-653BAF15-FF45-4760-9EB0-DE65B633146FQ63321366-AD832361-B971-4D92-9416-413D606E2FAFQ63338746-B038A138-5FAE-453B-A411-2E57E76FF613Q63341090-536B940C-3A7B-4F7D-B5F7-BD9C0B906BB4Q63572468-BA96F05F-42D8-4C2B-898D-C311DCC06060Q63811662-A8665368-A9AE-4C50-84ED-91B1987C7882Q87077275-2089A904-7E9C-4A0A-9123-04DA565A3507
P4844
Q33413261-9FE1C0A8-6D3E-4D71-9F8B-4F7303F4070EQ36345504-FEDECC85-90A2-4DD1-AF6F-48FC6133C271Q39256996-BF0568DF-8F41-4FF8-87E1-B3C863A2F6FDQ39450909-1032275A-B1CC-4E17-AE5B-4CAECCF35268Q46884416-BFCD0D12-BBBD-46CF-AFB9-B4839D3E7471Q47768821-58EA7D97-6D94-4F56-A540-CA3B35F24FD7Q48204247-16F3F54B-2C79-4C1D-A9FF-9B13E060C0E0Q49382840-FC5F3CC4-8C71-49D5-929C-74422CD15DAEQ49561589-5F42D1AC-D54F-4ED1-B0A9-EA488A2D9435Q49887268-EB515000-1F77-4384-B3C2-AD47AB27F95DQ64047721-78AB6AA9-EE61-42BA-95F1-D40C447D5B88Q64103810-C397762D-FF24-4EF7-BD94-7E923B4BBEBBQ64284319-2FE73A38-D573-4ACC-A35D-B1DC9767D59DQ86735429-48421E38-D932-4CB9-A91E-8747DCCB7B2A
P921
description
antybiotyk
@pl
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische Verbindung, Arzneistoff
@de
name
Dapson
@de
Dapson
@id
Dapson
@nb
Dapson
@sh
Dapson
@sl
Dapson
@sr
Dapson
@sr-el
Dapsona
@es
Dapsona
@oc
Dapsone
@ro
type
label
Dapson
@de
Dapson
@id
Dapson
@nb
Dapson
@sh
Dapson
@sl
Dapson
@sr
Dapson
@sr-el
Dapsona
@es
Dapsona
@oc
Dapsone
@ro
altLabel
1'-Sulfonylbis(4-aminobenzene)
@cy
1'-Sulfonylbis[4-aminobenzene]
@cy
1,1'-Sulfonylbis(4-aminobenzene)
@en
1,1'-Sulfonylbis[4-aminobenzene]
@en
4'-Dapsone
@cy
4'-Diaminodiphenyl sulfone
@cy
4'-Diaminodiphenyl sulphone
@cy
4'-Diaminodiphenylsulfone
@cy
4'-Sulfonylbisaniline
@cy
4'-Sulfonylbisbenzenamine
@cy
prefLabel
Dapson
@de
Dapson
@id
Dapson
@nb
Dapson
@sh
Dapson
@sl
Dapson
@sr
Dapson
@sr-el
Dapsona
@es
Dapsona
@oc
Dapsone
@ro